These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 812047)

  • 61. Clinical evaluation of patients treated for rhabdomyosarcoma.
    Swierzowa J
    Pol Med J; 1972; 11(5):1299-304. PubMed ID: 4630761
    [No Abstract]   [Full Text] [Related]  

  • 62. [On hematopoietic changesin patients with malignant ovarian tumors during chemotherapy].
    Turbina IL; Mezentseva SK
    Vopr Onkol; 1965; 11(8):38-41. PubMed ID: 4957708
    [No Abstract]   [Full Text] [Related]  

  • 63. [Hemosorption and polychemotherapy with hyperglycemia in the treatment of ovarian cancer].
    Lisetskiĭ VA; Evtushenko GV; Dotsenko IuS; Svintsitskiĭ VS
    Vrach Delo; 1990 Apr; (4):87-9. PubMed ID: 2125767
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Chemotherapy of epithelial ovarian cancer: CHexUP versus thio-tepa].
    Wu BZ
    Zhonghua Fu Chan Ke Za Zhi; 1987 Jan; 22(1):5-8, 61. PubMed ID: 3109851
    [No Abstract]   [Full Text] [Related]  

  • 65. [Prognosis in cancer of the ovaries].
    Nerodo GA
    Vopr Onkol; 1974; 20(8):45-50. PubMed ID: 4215222
    [No Abstract]   [Full Text] [Related]  

  • 66. [Controlled prospective study of chemotherapy in advanced ovarian cancer--cyclophosphamide monochemotherapy versus polychemotherapy with adriamycin, cyclophosphamide, 5-fluorouracil and methotrexate].
    Chylak V; Kolarić K; Krusić J
    Lijec Vjesn; 1987 Jun; 109(6):230-4. PubMed ID: 3309515
    [No Abstract]   [Full Text] [Related]  

  • 67. [Radiotherapy in the treatment of malignant epithelial neoplasias of the ovary (experience in 94 cases)].
    Torres Lobatón A; García Baños J; Nieto Riande P; Díaz Perches R
    Rev Invest Clin; 1985; 37(4):317-22. PubMed ID: 4095399
    [No Abstract]   [Full Text] [Related]  

  • 68. Cytotoxic agents in the treatment of malignant disease.
    Br Med J; 1968 Nov; 4(5628):438-9. PubMed ID: 4972069
    [No Abstract]   [Full Text] [Related]  

  • 69. The treatment of ovarian cancer.
    Sall S; Stone ML
    Prog Clin Cancer; 1973; 5():249-62. PubMed ID: 4692475
    [No Abstract]   [Full Text] [Related]  

  • 70. [Approach to combined treatment of lung cancer].
    Pirogov AI; Trakhtenberg AKh; Kiseleva ES
    Sov Med; 1976 Aug; (8):82-8. PubMed ID: 827027
    [No Abstract]   [Full Text] [Related]  

  • 71. High dose thiotepa in ovarian cancer.
    Shetty PA; Kurkure PA; Pai VR; Gohokar D; Pai S; Shinde SR; D'Souza LJ; Sampat MB
    Indian J Cancer; 1985 Mar; 22(1):33-7. PubMed ID: 3939232
    [No Abstract]   [Full Text] [Related]  

  • 72. Accuracy, feasibility, and clinical impact of prospective Bayesian pharmacokinetically guided dosing of cyclophosphamide, thiotepa, and carboplatin in high-dose chemotherapy.
    de Jonge ME; Huitema AD; Tukker AC; van Dam SM; Rodenhuis S; Beijnen JH
    Clin Cancer Res; 2005 Jan; 11(1):273-83. PubMed ID: 15671556
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Radiotherapy in the complex treatment of malignant tumors of the ovaries].
    Mitrov GG; Mlychkov KhN; Khristov IN
    Med Radiol (Mosk); 1968 Jan; 13(1):3-8. PubMed ID: 5742265
    [No Abstract]   [Full Text] [Related]  

  • 74. [Comparative study of thiotepa and adriamycin as preventive intravesical treatment in non-infiltrating bladder tumors].
    Lancina Martín JA; Mateo Cambón L; Casas Muiño RA; González Martín M
    Actas Urol Esp; 1983; 7(4):269-74. PubMed ID: 6414263
    [No Abstract]   [Full Text] [Related]  

  • 75. Pharmacokinetics of continuous-infusion high-dose thiotepa.
    Henner WD; Shea TC; Furlong EA; Flaherty MD; Eder JP; Elias A; Begg C; Antman K
    Cancer Treat Rep; 1987 Nov; 71(11):1043-7. PubMed ID: 3119200
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Our observations on the treatment of ovarian carcinoma with cytostatics].
    Krstalić V; Krstalić N
    Med Pregl; 1978; 31(11-12):521-2. PubMed ID: 739967
    [No Abstract]   [Full Text] [Related]  

  • 77. [A histochemical study of Shick-positive substances in cancerous tumors of the ovaries treated with thio-TEPA].
    Kasab'ian SS; Zaĭchenko IuM
    Akush Ginekol (Mosk); 1972 Jun; 48(6):71-3. PubMed ID: 4262647
    [No Abstract]   [Full Text] [Related]  

  • 78. [The use of Thio-TEPA in patients with malignant diseases of the ovary].
    Kuz'mina NA
    Akush Ginekol (Mosk); 1966 Apr; 42(4):10-3. PubMed ID: 4965157
    [No Abstract]   [Full Text] [Related]  

  • 79. [Results of clinico-roentgenologic observations in the complex treatment of malignant tumors of the ovaries].
    Vaĭtkiavichius IA; Ambrozaitis KI
    Vopr Onkol; 1967; 13(1):38-43. PubMed ID: 5601820
    [No Abstract]   [Full Text] [Related]  

  • 80. Early stage ovarian cancer. The effect of adjuvant treatment with a single alkylating agent.
    Davy M; Stenwig AE; Kjørstad KE; Berle E
    Acta Obstet Gynecol Scand; 1985; 64(6):531-2. PubMed ID: 3933277
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.